Related Experiment Video
Updated: Aug 24, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Lateral reticular formation as a site for morphine- and clonidine-induced hypotension
Abstract:
The possible role of the lateral reticular formation (LRF) in morphine-induced hypotension was investigated. Morphine (5-10 micrograms) microinjected into 15 of 25 sites in the LRF of anesthetized cats reduced mean (+/- S.E.) arterial pressure by 18.4 +/- 2.1 mmHg. Morphine applied microiontophoretically on LRF neurons had a predominately inhibitory effect on LRF cells, decreasing spontaneous rate in 51%. Since the LRF has been suggested as a site of action for clonidine-induced hypotension, clonidine was also applied microiontophoretically to these neurons. Of the cells evaluated, 43% were inhibited by clonidine. Individual cells typically responded in the same manner to morphine and clonidine. An inhibition of LRF cells by morphine and clonidine is consistent with their hypotensive action and the tonic vasopressive role assigned to the LRF. Collectively, these results suggest that the LRF is a site at which morphine and clonidine may produce their hypotensive effect.
More Related Videos
Related Concept Videos
Opioid Receptors: Overview
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...

